Percentage of revefenacin and its metabolites identified in pooled plasma after a single intravenous dose of 20 μg [14C]-revefenacin (n = 6) and an oral dose of 200 μg [14C]-revefenacin (n = 6)
[14C]-revefenacin, [14C]-labeled revefenacin.
| Circulating Radioactivity (%) Intravenous | Circulating Radioactivity (%) Oral | |
|---|---|---|
| Revefenacin | 52.1 | 13.1 |
| THRX-195518 (M2) | 14.3 | 12.5 |
| THRX-697795 (M10) | 4.79 | 12.5 |
| THRX-193305 (M9) | 2.81 | 2.93 |
| THRX-609075 (M1) | 1.66 | 3.63 |
| THRX-177860 (M8) | 1.58 | 3.69 |